title: Akt is required for Stat5 activation and mammary differentiation.
abstract: BACKGROUND
  The Akt pathway plays a central role in regulating cell survival, proliferation and metabolism, and is one of the most commonly activated pathways in human cancer. A role for Akt in epithelial differentiation, however, has not been established. We previously reported that mice lacking Akt1, but not Akt2, exhibit a pronounced metabolic defect during late pregnancy and lactation that results from a failure to upregulate Glut1 as well as several lipid synthetic enzymes. Despite this metabolic defect, however, both Akt1-deficient and Akt2-deficient mice exhibit normal mammary epithelial differentiation and Stat5 activation.
  
  
  METHODS
  In light of the overlapping functions of Akt family members, we considered the possibility that Akt may play an essential role in regulating mammary epithelial development that is not evident in Akt1-deficient mice due to compensation by other Akt isoforms. To address this possibility, we interbred mice bearing targeted deletions in Akt1 and Akt2 and determined the effect on mammary differentiation during pregnancy and lactation.
  
  
  RESULTS
  Deletion of one allele of Akt2 in Akt1-deficient mice resulted in a severe defect in Stat5 activation during late pregnancy that was accompanied by a global failure of terminal mammary epithelial cell differentiation, as manifested by the near-complete loss in production of the three principal components of milk: lactose, lipid, and milk proteins. This defect was due, in part, to a failure of pregnant Akt1(-/-);Akt2(+/-) mice to upregulate the positive regulator of Prlr-Jak-Stat5 signaling, Id2, or to downregulate the negative regulators of Prlr-Jak-Stat5 signaling, caveolin-1 and Socs2.
  
  
  CONCLUSIONS
  Our findings demonstrate an unexpected requirement for Akt in Prlr-Jak-Stat5 signaling and establish Akt as an essential central regulator of mammary epithelial differentiation and lactation.
authors.affiliation: Department of Cancer Biology, University of Pennsylvania School of Medicine, Philadelphia, 19104, USA.
authors.forename: Chien-Chung
authors.initials: CC
authors.lastname: Chen
authors.forename: Robert B
authors.initials: RB
authors.lastname: Boxer
authors.forename: Douglas B
authors.initials: DB
authors.lastname: Stairs
authors.forename: Carla P
authors.initials: CP
authors.lastname: Portocarrero
authors.forename: Rachel H
authors.initials: RH
authors.lastname: Horton
authors.forename: James V
authors.initials: JV
authors.lastname: Alvarez
authors.forename: Morris J
authors.initials: MJ
authors.lastname: Birnbaum
authors.forename: Lewis A
authors.initials: LA
authors.lastname: Chodosh
mesh_terms: D000818:Animals; D002454:Cell Differentiation; D049109:Cell Proliferation; D002470:Cell Survival; D005260:Female; D053612:Janus Kinases / Q000378:metabolism; D007774:Lactation; D008321:Mammary Glands, Animal / Q000166:cytology* / Q000378:metabolism*; D051379:Mice; D018345:Mice, Knockout; D008894:Milk Proteins / Q000096:biosynthesis; D009924:Organ Culture Techniques; D051057:Proto-Oncogene Proteins c-akt / Q000235:genetics / Q000378:metabolism*; D050799:STAT5 Transcription Factor / Q000378:metabolism*; D015398:Signal Transduction
chemical_list: D008894:Milk Proteins; D050799:STAT5 Transcription Factor; D053612:Janus Kinases; C514862:Akt1 protein, mouse; C494922:Akt2 protein, mouse; C491753:Akt3 protein, mouse; D051057:Proto-Oncogene Proteins c-akt